Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Deferred Taxes (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Deferred Taxes for 17 consecutive years, with -$392.0 million as the latest value for Q4 2025.

  • Quarterly Deferred Taxes rose 50.44% to -$392.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$965.0 million through Dec 2025, up 53.81% year-over-year, with the annual reading at -$965.0 million for FY2025, 53.81% up from the prior year.
  • Deferred Taxes for Q4 2025 was -$392.0 million at Bristol Myers Squibb, down from -$359.0 million in the prior quarter.
  • The five-year high for Deferred Taxes was $223.0 million in Q1 2025, with the low at -$1.3 billion in Q4 2023.
  • Average Deferred Taxes over 5 years is -$523.6 million, with a median of -$492.5 million recorded in 2023.
  • The sharpest move saw Deferred Taxes soared 228.3% in 2021, then crashed 1915.62% in 2022.
  • Over 5 years, Deferred Taxes stood at -$1.3 billion in 2021, then skyrocketed by 50.71% to -$624.0 million in 2022, then crashed by 112.66% to -$1.3 billion in 2023, then surged by 40.39% to -$791.0 million in 2024, then skyrocketed by 50.44% to -$392.0 million in 2025.
  • According to Business Quant data, Deferred Taxes over the past three periods came in at -$392.0 million, -$359.0 million, and -$437.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.